Skip to content

Change in AR at other companies

Pfizer logo
PfizerPFE
$65.75M+141%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$19.55M+610%
Viatris logo
ViatrisVTRS
$126.3M+175%
Opko Health logo
Opko HealthOPK
-$9.53M+58.5%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$839K-25.6%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$44.01M-108%

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$927.72M-19.9%
Enterprise value$1.44B-11.3%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%
Debt / equity0.2×
Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's change in AR?
Amphastar Pharmaceuticals (AMPH) reported change in AR of $4.55M in Q1 2026.
How has Amphastar Pharmaceuticals's change in AR changed year-over-year?
Amphastar Pharmaceuticals's change in AR decreased by 43.7% year-over-year, from $8.08M to $4.55M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.